共 50 条
- [21] MULTISTATE MODEL ANALYSIS OF PROPHYLACTIC/PREEMPTIVE DONOR LYMPHOCYTE INFUSION FOR HIGH-RISK ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME IN COMPLETE HEMATOLOGIC REMISSION AFTER ALLOGENEIC STEM CELL TRANSPLANTATIONBONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 231 - 232Velazquez, Giuliano FilippiniWeller, Jan FredericRubeck, AnnaArndt, TobiasSchiele, StefanMezger, MarkusMueller, GernotLengerke, ClaudiaTrepel, MartinChristopeit, MaximilianSchmid, Christoph
- [22] Regular Prophylactic Donor Lymphocyte Infusion Is Effective and Safe to Prevent Relapse after Hematopoietic Cell Transplantation in High-Risk PatientsBLOOD, 2016, 128 (22)Luo, YiTan, YaminHu, YongxianShi, JiminZheng, WeiyanZhao, YanminZhu, YuanyuanYu, JianWang, JiashengHuang, He
- [23] Prophylactic growth factor-primed donor lymphocyte infusion using cells reserved at the time of transplantation after allogeneic peripheral blood stem cell transplantation in patients with high-risk hematologic malignanciesCANCER, 2002, 94 (01) : 18 - 24Sohn, SKJung, JTKim, DHLee, NYSeo, KWChae, YSPark, SWKim, JGSuh, JSLee, KB
- [24] Donor lymphocyte infusion for the treatment of relapse after allogeneic hematopoietic stem cell transplantationLEUKEMIA & LYMPHOMA, 1998, 29 (3-4) : 301 - 313Helg, CStarobinski, MJeannet, MChapuis, B
- [25] Donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantationEXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (04) : 473 - 487Roddie, ClairePeggs, Karl S.
- [26] MRD as Biomarker for Response to Donor Lymphocyte Infusion after Allogeneic Hematopoietic Cell Transplantation in Patients with AMLCANCERS, 2023, 15 (15)Teich, KatrinStadler, MichaelGabdoulline, RazifKandarp, JyotiWienecke, ClaraHeida, BennetKlement, PiroskaButtner, KonstantinVenturini, LetiziaWichmann, MartinPuppe, WolframSchultze-Florey, ChristianKoenecke, ChristianBeutel, GernotEder, MatthiasGanser, ArnoldHeuser, MichaelThol, Felicitas
- [27] Azacitidine and prophylactic donor lymphocyte infusions after hematopoietic stem cell transplantation for pediatric high-risk acute myeloid leukemiaPEDIATRIC HEMATOLOGY AND ONCOLOGY, 2021, 38 (02) : 154 - 160Huschart, EmilyMiller, HollySalzberg, DanaCampbell, CourtneyBeebe, KristenSchwalbach, CharlotteMagee, KyrieAdams, Roberta H.Ngwube, Alexander
- [28] On behalf of the SFGM-TC: prophylactic donor lymphocyte infusion in patients treated with allogeneic stem-cell transplantation for high-risk myelodysplastic syndrome and acute myeloid leukemiaACTA HAEMATOLOGICA, 2023, 146 (03) : 230 - 239Guisnel, CharlesSchirmer, LucianeMorisset, StephaneRobin, MarieLabussiere-Wallet, HeleneDulery, RemyCeballos, PatriceForcade, EdouardNguyen-Quoc, StephaniePoire, XavierMaertens, JohanChantepie, SylvainChevallier, PatriceDaguindau, EtienneVillate, AlbanCharbonnier, AmandineCastilla-Llorente, CristinaContentin, NathalieHuynh, AnneYakoub-Agha, IbrahimBulabois, Claude-EricRubio, Marie-ThereseD'Aveni, Maud
- [29] Repetitively Administered Low-Dose Donor Lymphocyte Infusion for Prevention of Relapse after Allogeneic Stem Cell Transplantation in Patients with High-Risk Acute LeukemiaCANCERS, 2021, 13 (11)Tsirigotis, PanagiotisGkirkas, KonstantinosKitsiou, VassilikiChondropoulos, SpirosAthanassiades, TheofilosThomopoulos, ThomasTsirogianni, AlexandraStamouli, MariaKaragiannidi, AggelikiSiafakas, NikolaosPappa, VassilikiNagler, Arnon
- [30] Prophylactic donor lymphocyte infusion after allogeneic haematopoieitc transplantation in patients with acute leukaemiaBONE MARROW TRANSPLANTATION, 2011, 46 : S202 - S202Liga, M.Triantafyllou, E.Karakantza, M.Spyridonidis, A.